{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:35:57Z","timestamp":1789122957466,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1245\/s10434-021-09626-3","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T16:05:47Z","timestamp":1614960347000},"page":"2675-2682","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Conditional Recurrence-Free Survival after Oncologic Extended Resection for Gallbladder Cancer: An International Multicenter Analysis"],"prefix":"10.1245","volume":"28","author":[{"given":"Eduardo A.","family":"Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Newhook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikuni","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"De Bellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Panettieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Duwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Piccino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino M.","family":"De Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ruzzenente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Uemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Vivanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Shin","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hop S. Tran","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Wei D.","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xabier","family":"De Aretxabala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Giuliante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Vinuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Nicolas","family":"Vauthey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"issue":"8","key":"9626_CR1","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1245\/s10434-017-5859-6","volume":"24","author":"E Vinuela","year":"2017","unstructured":"Vinuela E, Vega EA, Yamashita S, et al. Incidental gallbladder cancer: residual cancer discovered at oncologic extended resection determines outcome: a report from high- and low-incidence countries. Ann Surg Oncol. 2017;24(8):2334\u201343.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"9626_CR2","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.hpb.2016.05.016","volume":"18","author":"GA Margonis","year":"2016","unstructured":"Margonis GA, Gani F, Buettner S, et al. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB. 2016;18(11):872\u20138.","journal-title":"HPB."},{"issue":"8","key":"9626_CR3","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/cncr.11699","volume":"98","author":"WR Jarnagin","year":"2003","unstructured":"Jarnagin WR, Ruo L, Little SA, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98(8):1689\u2013700.","journal-title":"Cancer."},{"issue":"3","key":"9626_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jamcollsurg.2019.04.027","volume":"229","author":"Y Kawaguchi","year":"2019","unstructured":"Kawaguchi Y, Lillemoe HA, Panettieri E, et al. Conditional recurrence-free survival after resection of colorectal liver metastases: persistent deleterious association with RAS and TP53 co-mutation. J Am Coll Surg. 2019;229(3):286-294.e281.","journal-title":"J Am Coll Surg."},{"issue":"2","key":"9626_CR5","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1097\/SLA.0000000000003610","volume":"271","author":"Y Kawaguchi","year":"2020","unstructured":"Kawaguchi Y, Lillemoe HA, Vauthey JN. Comment on \u201cReappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma.\u201d Ann Surg. 2020;271(2):e17.","journal-title":"Ann Surg."},{"issue":"1","key":"9626_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/ssu.2980100103","volume":"10","author":"DE Henson","year":"1994","unstructured":"Henson DE, Ries LA. On the estimation of survival. Semin Surg Oncol . 1994;10(1):2\u20136.","journal-title":"Semin Surg Oncol."},{"issue":"1","key":"9626_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40880-017-0252-1","volume":"36","author":"YJ Kim","year":"2017","unstructured":"Kim YJ, Kim K. Conditional survival in patients with gallbladder cancer. Chin J Cancer. 2017;36(1):85.","journal-title":"Chin J Cancer."},{"issue":"13","key":"9626_CR8","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1245\/s10434-016-5470-2","volume":"23","author":"S Buettner","year":"2016","unstructured":"Buettner S, Margonis GA, Kim Y, et al. Changing odds of survival over time among patients undergoing surgical resection of gallbladder carcinoma. Ann Surg Oncol. 2016;23(13):4401\u20139.","journal-title":"Ann Surg Oncol."},{"key":"9626_CR9","doi-asserted-by":"crossref","unstructured":"Vega EA, Vinuela E, Okuno M, et al. Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors. HPB. Jan 30 2019.","DOI":"10.1016\/j.hpb.2018.12.006"},{"key":"9626_CR10","doi-asserted-by":"crossref","unstructured":"Vega EA, Vinuela E, Sanhueza M, et al. Positive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticator. Eur J Surg Oncol. 2019.","DOI":"10.1016\/j.hpb.2018.02.057"},{"key":"9626_CR11","unstructured":"Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2017;17(6):1471-1474."},{"issue":"7","key":"9626_CR12","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1245\/s10434-009-0899-1","volume":"17","author":"J Sakata","year":"2010","unstructured":"Sakata J, Shirai Y, Wakai T, Ajioka Y, Hatakeyama K. Number of positive lymph nodes independently determines the prognosis after resection in patients with gallbladder carcinoma. Ann Surg Oncol. 2010;17(7):1831\u201340.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"9626_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg."},{"key":"9626_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/BFb0098486","volume-title":"Smoothing Techniques for Curve Estimation","author":"HG Gasser TaM","year":"1979","unstructured":"Gasser TaM HG. Smoothing Techniques for Curve Estimation. Berlin: Springer; 1979."},{"issue":"3","key":"9626_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/CIRCOUTCOMES.110.957951","volume":"4","author":"U Dafni","year":"2011","unstructured":"Dafni U. Landmark analysis at the 25-year landmark point. Circ Cardiovasc Qual Outcomes. 2011;4(3):363\u201371.","journal-title":"Circ Cardiovasc Qual Outcomes."},{"issue":"8","key":"9626_CR16","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1007\/s00520-016-3272-5","volume":"24","author":"S Lebel","year":"2016","unstructured":"Lebel S, Ozakinci G, Humphris G, et al. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016;24(8):3265\u20138.","journal-title":"Support Care Cancer."},{"issue":"5","key":"9626_CR17","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/cncr.32014","volume":"125","author":"C Printz","year":"2019","unstructured":"Printz C. More research needed to help survivors with fear of recurrence. Cancer. 2019;125(5):665.","journal-title":"Cancer."},{"key":"9626_CR18","unstructured":"National Comprehensive Cancer Network. Hepatobiliary Cancers (Version 1.2019). 2018; https:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/hepatobiliary.pdf. Accessed February 15, 2019."},{"issue":"14","key":"9626_CR19","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273\u201381.","journal-title":"N Engl J Med."},{"issue":"8","key":"9626_CR20","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/cncr.10831","volume":"95","author":"T Takada","year":"2002","unstructured":"Takada T, Amano H, Yasuda H, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002;95(8):1685\u201395.","journal-title":"Cancer."},{"issue":"24","key":"9626_CR21","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1200\/JCO.2014.60.2219","volume":"33","author":"E Ben-Josef","year":"2015","unstructured":"Ben-Josef E, Guthrie KA, El-Khoueiry AB, et al. SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol. 2015;33(24):2617\u201322.","journal-title":"J Clin Oncol."},{"issue":"4_suppl","key":"9626_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1200\/JCO.2017.35.4_suppl.225","volume":"35","author":"J Edeline","year":"2017","unstructured":"Edeline J, Bonnetain F, Phelip JM, et al. Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial. J Clin Oncol. 2017;35(4_suppl):225\u2013225.","journal-title":"J Clin Oncol."},{"issue":"15_suppl","key":"9626_CR23","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1200\/JCO.2017.35.15_suppl.4006","volume":"35","author":"JN Primrose","year":"2017","unstructured":"Primrose JN, Fox R, Palmer DH, et al. Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study. J Clin Oncol. 2017;35(15_suppl):4006\u20134006.","journal-title":"J Clin Oncol."},{"issue":"4","key":"9626_CR24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.humpath.2013.11.001","volume":"45","author":"M Javle","year":"2014","unstructured":"Javle M, Rashid A, Churi C, et al. Molecular characterization of gallbladder cancer using somatic mutation profiling. Hum Pathol. 2014;45(4):701\u20138.","journal-title":"Hum Pathol."},{"key":"9626_CR25","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/S0959-8049(16)30326-4","volume":"51","author":"YJ Bang","year":"2012","unstructured":"Bang YJ, Doi T, Braud FD, et al. 525 Safety and efficacy of pembrolizumab (MK-3475) in patients (pts) with advanced biliary tract cancer: Interim results of KEYNOTE-028. Eur J Cancer. 2012;51:S112.","journal-title":"Eur J Cancer."},{"issue":"6230","key":"9626_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","volume":"348","author":"P Sharma","year":"2015","unstructured":"Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348(6230):56\u201361.","journal-title":"Science"},{"key":"9626_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2776(06)90001-7","volume":"90","author":"MJ Smyth","year":"2006","unstructured":"Smyth MJ, Dunn GP, Schreiber RD. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol. 2006;90:1\u201350.","journal-title":"Adv Immunol."},{"issue":"9","key":"9626_CR28","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/sj.bjc.6601331","volume":"89","author":"Y Nakakubo","year":"2003","unstructured":"Nakakubo Y, Miyamoto M, Cho Y, et al. Clinical significance of immune cell infiltration within gallbladder cancer. Br J Cancer. 2003;89(9):1736\u201342.","journal-title":"Br J Cancer."},{"issue":"10","key":"9626_CR29","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1038\/bjc.2013.610","volume":"109","author":"B Goeppert","year":"2013","unstructured":"Goeppert B, Frauenschuh L, Zucknick M, et al. Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer. Br J Cancer. 2013;109(10):2665\u201374.","journal-title":"Br J Cancer."},{"issue":"7","key":"9626_CR30","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.humpath.2004.03.016","volume":"35","author":"S Takagi","year":"2004","unstructured":"Takagi S, Miyagawa S, Ichikawa E, et al. Dendritic cells, T-cell infiltration, and Grp94 expression in cholangiocellular carcinoma. Hum Pathol. 2004;35(7):881\u20136.","journal-title":"Hum Pathol."},{"issue":"4","key":"9626_CR31","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/jso.10321","volume":"84","author":"T Oshikiri","year":"2003","unstructured":"Oshikiri T, Miyamoto M, Shichinohe T, et al. Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response. J Surg Oncol. 2003;84(4):224\u20138.","journal-title":"J Surg Oncol."},{"issue":"6184","key":"9626_CR32","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1126\/science.1251102","volume":"344","author":"E Tran","year":"2014","unstructured":"Tran E, Turcotte S, Gros A, et al. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science. 2014;344(6184):641\u20135.","journal-title":"Science"},{"issue":"3","key":"9626_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1200\/jco.2015.33.3_suppl.285","volume":"33","author":"RF Holcombe","year":"2015","unstructured":"Holcombe RF, Xiu J, Pishvaian MJ, et al. Tumor profiling of biliary tract carcinomas to reveal distinct molecular alterations and potential therapeutic targets. J Clin Oncol. 2015;33(3):285\u2013285.","journal-title":"J Clin Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09626-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-09626-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09626-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T17:31:58Z","timestamp":1618335118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-09626-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["9626"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-09626-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"16 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None of the authors declare any conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}